Profile
Corporate information
Registration country
Registration country
Investment activity status
Active investor
Company type
Biopharmaceutical company focused on bispecific antibodies.Funding
Funding rounds
Series A USD 25,000,000
USD 25,000,000 (25 Apr 2017)
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
Oriza Seed Venture Capital | Led the round. | ||
|
|
3E Bioventures Capital | Round participant. | ||
|
Decheng Capital | Round participant. | ||
|
|
Trend Investments Group LLC | United States | Round participant. |